(Q36161246)

12 August 2017

1 reference

title

Defining the need for new antimicrobials: clinical and economic implications of resistance in the hospitalised patient (English)

1 reference

12 August 2017

1 reference

3

David P Nicolau

1 reference

12 August 2017

C Andrew DeRyke

1

1 reference

12 August 2017

Dana Maglio

series ordinal

2

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 June 2005

1 reference

Expert Opinion on Pharmacotherapy

12 August 2017

published in

1 reference

12 August 2017

volume

6

1 reference

12 August 2017

issue

6

1 reference

12 August 2017

page(s)

873-889

1 reference

Cost-effective approaches to the treatment of community-acquired pneumonia in the era of resistance

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Comparison of Streptococcus pneumoniae and Haemophilus influenzae susceptibilities from community-acquired respiratory tract infections and hospitalized patients with pneumonia: five-year results for the SENTRY Antimicrobial Surveillance Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Pharmacodynamics of fluoroquinolones against Streptococcus pneumoniae in patients with community-acquired respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Emergence of levofloxacin-resistant pneumococci in immunocompromised adults after therapy for community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Resistance to levofloxacin and failure of treatment of pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. Canadian Bacterial Surveillance Network.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Antibiotic resistance among gram-negative bacilli in US intensive care units: implications for fluoroquinolone use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

The in vivo-in vitro paradox in pneumococcal respiratory tract infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

An international prospective study of pneumococcal bacteremia: correlation with in vitro resistance, antibiotics administered, and clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

The clinical significance of macrolide-resistant Streptococcus pneumoniae: it's all relative

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Molecular characterization of fluoroquinolone resistant Streptococcus pneumoniae clinical isolates obtained from across Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Health care resource utilization associated with treatment of penicillin-susceptible and -nonsusceptible isolates of Streptococcus pneumoniae.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2003, issued August 2003.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Antimicrobial resistance in intensive care units

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Vancomycin-resistant Staphylococcus aureus isolate from a patient in Pennsylvania

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Community-acquired methicillin-resistant Staphylococcus aureus: a meta-analysis of prevalence and risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Trimethoprim-sulfamethoxazole compared with vancomycin for the treatment of Staphylococcus aureus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Clindamycin treatment of Staphylococcus aureus expressing inducible clindamycin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Outcome and attributable mortality in critically Ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Bacteremic pneumonia due to Staphylococcus aureus: A comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Clinical cure and survival in Gram-positive ventilator-associated pneumonia: retrospective analysis of two double-blind studies comparing linezolid with vancomycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

A nationwide, multicenter, case-control study comparing risk factors, treatment, and outcome for vancomycin-resistant and -susceptible enterococcal bacteremia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Clinical outcomes for patients with bacteremia caused by vancomycin-resistant enterococcus in a level 1 trauma center

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Health and economic outcomes of vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Therapeutic challenges associated with extended-spectrum, beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Clinical and molecular epidemiology of acinetobacter infections sensitive only to polymyxin B and sulbactam

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial Klebsiella

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Relationship between fluoroquinolone use and changes in susceptibility to fluoroquinolones of selected pathogens in 10 United States teaching hospitals, 1991-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Predicting hospital rates of fluoroquinolone-resistant Pseudomonas aeruginosa from fluoroquinolone use in US hospitals and their surrounding communities

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Nosocomial bacteremia caused by antibiotic-resistant gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Outcomes analysis of delayed antibiotic treatment for hospital-acquired Staphylococcus aureus bacteremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Beta lactam monotherapy versus beta lactam-aminoglycoside combination therapy for fever with neutropenia: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Experience with a clinical guideline for the treatment of ventilator-associated pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Oritavancin and tigecycline: investigational antimicrobials for multidrug-resistant bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Tetracycline therapy: update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Results of a multicenter, randomized, open-label efficacy and safety study of two doses of tigecycline for complicated skin and skin-structure infections in hospitalized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

The Value of Routine Microbial Investigation in Ventilator-Associated Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

National Nosocomial Infections Surveillance (NNIS) System Report, Data Summary from January 1992-June 2001, issued August 2001

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

Failure of Macrolide Antibiotic Treatment in Patients with Bacteremia Due to Erythromycin‐Resistant Streptococcus pneumoniae

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.6.6.873

21 January 2018

Identifiers

DOI

10.1517/14656566.6.6.873

1 reference

release_mawg2nubhzcjrew7wof3gnqmgy

12 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/mawg2nubhzcjrew7wof3gnqmgy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference